Search results
Results From The WOW.Com Content Network
In 2004–5, the Indian biotech industry saw its revenues grow 37% to $1.1 billion. The Indian biotech market is dominated by biopharmaceuticals; 76% of 2004–5 revenues came from biopharmaceuticals, which saw 30% growth last year. Of the revenues from biopharmaceuticals, vaccines led the way, comprising 47% of sales.
Dinamalar Publications Ltd. 17 Sandesh: Gujarati: 5 cities in Gujarat and in Mumbai: 2.884 The Sandesh Ltd. 18 Prabhat Khabar: Hindi: Various cities in Jharkhand, Bihar, and West Bengal: 2.872 Neutral Publishing House Ltd. 19 Bartaman: Bengali: West Bengal, Odisha, Jharkhand, Bihar, Delhi, Mumbai and other cities in India 2.750 Bartaman Pvt ...
Tripadvisor, Inc. is an American company that operates online travel agencies, comparison shopping websites, and mobile apps with user-generated content. [1]Its namesake brand, Tripadvisor.com, operates in 40 countries and 20 languages, and features approximately 1 billion reviews and opinions on roughly 8 million establishments. [1]
The first Indian biotechnology company to be established was Biocon, which was founded by Kiran Mazumdar-Shaw in 1978. [3] The Indian biotechnology industry formally began in 1986 with the establishment of the Department of Biotechnology (DBT) by the Ministry of Science and Technology. [4]
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. [ 10 ] The company's key focus areas include paediatrics , cardiovascular , anti-infectives , diabetology , asthma and anti-tuberculosis .
Piramal Pharma Limited is active in business verticals including pharmaceuticals, healthcare and life sciences.Its business divisions include Piramal Pharma Solutions, a contract development and manufacturing organization; Piramal Critical Care, a manufacturer of inhalational anesthetics and other hospital generics; and Piramal Consumer Products Division, an over-the-counter consumer ...
Panacea Biotec has a focused presence in nephrology therapy in the highly specialized organ transplantation and dialysis management segments. It offers a range of pre-transplant and post-transplant therapies that include drugs such as lanthanum carbonate, sevelamer, and valganciclovir in conventional and novel drug delivery systems.
Concord Biotech was founded in 2000 by Sudhir Vaid, a former director at Ranbaxy Laboratories. [4] It was the first company in India and the second in the world to develop an anti-immuno suppressant tacrolimus. [7] In 2004, Rakesh Jhunjhunwala acquired around 14% stake in the company.